Please login or register first to view this content.
Endocrine Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Once-Weekly Insulin Icodec Superior to Daily Insulin Degludec in Reducing HbA1c
Underuse of Diabetic Kidney Disease Therapies Reported
Hospital Outcomes Worse With Suboptimal Treatment of Hypothyroidism
Missing Label on Vial Prompts Recall of Long-Acting Insulin Analog
Renal Denervation Offers Sustained Blood Pressure Reduction
Trial Evaluating Pemafibrate to Reduce CV Outcomes in Diabetes Patients Discontinued
March 2022: Drug Pipeline Updates
GLP-1 RA Use May Up Risk for Gallbladder, Biliary Diseases
Preconception Paternal Metformin Linked to Major Birth Defects
FDA: Monitor Young Children for Thyroid Dysfunction After Exposure to Iodinated Contrast Media
Ozempic 2mg Dose Approved to Provide Additional Glycemic Control in Type 2 Diabetes
FDA Accepts Resubmitted Teplizumab BLA for T1D Delay
No Change in TSH Level Seen With Switch in Generic LT4 Products
Gvoke Kit Now Available for Severe Hypoglycemia
Hypoparathyroidism Effectively Managed With TransCon PTH in Phase 3 Trial
SGLT2 Inhibitors for Diabetes May Protect Against AKI, Increase UTI Risk
Lipid Profiling Can Predict Future Risk for Type 2 Diabetes, CVD
Six Percent With Prediabetes Develop Diabetes Within 1 Year
